GD-29

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameGD-29
Drug Alias NameGD-29
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 betaAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A